SS, which is also considered a stem cell malignancy resulting from dysregulation of self-renewal and multi-lineage differentiation capacities induced by SS18-SSX oncoproteins, displays expression of neural tissue-related genes [1, 44, 53, 125]. The gene discussed is SS18; the disease is synovial sarcoma.